Clinical Trials Logo

Filter by:
NCT ID: NCT05815342 Completed - Type2 Diabetes Clinical Trials

OP5-005 Using Omnipod 5 in Adults With Type 2

SECURE-T2D
Start date: April 11, 2023
Phase: N/A
Study type: Interventional

This is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.

NCT ID: NCT05814367 Completed - Visual Acuity Clinical Trials

Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops

Start date: April 6, 2023
Phase: Phase 2
Study type: Interventional

This will be a single-visit, multi-site, randomized, single-masked, bilateral, active-controlled, non-dispensing, 2X2 crossover study.

NCT ID: NCT05814315 Completed - Pain Clinical Trials

Harnessing Online Peer Education Opioid Study

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The investigators have created an online peer support platform for chronic pain patients on opioid medications. This platform provides peer support and online mental health counselor run support groups to help participants manage pain and not abuse opioid medications.

NCT ID: NCT05813717 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants

Start date: April 10, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BMS-986325 in healthy Japanese participants

NCT ID: NCT05813548 Completed - Weight Loss Clinical Trials

The Effectiveness on an Application-Based Lifestyle Change Program on Health in Women

Start date: February 28, 2023
Phase: N/A
Study type: Interventional

The purpose of this study will be to examine the effectiveness of an application-based lifestyle change program on body composition, body shape, body, image, and self-esteem in females following a 6-week period. The study will be carried out in a randomized, placebo-controlled, parallel manner. Participants will be stratified into quartiles based on their body mass indices during screening and prior to baseline testing. Participants from each quartile will be randomly divided by into experimental or control conditions. Following randomization, participants will be baseline assessed on their body composition using a whole body Dual Energy X-Ray Absorptiometry scan, on their subjective measures of body shape and image using a variety of questionnaires, blood chemistry panel, and lower-body strength using a isometric mid-thigh pull dynamometer. Following baseline testing, participants will undergo 6-weeks of following their respective condition. Participants will be instructed to follow their group-specific guidelines for the 6-week period to the best of their ability. Body shape and image questionnaires and assessments of body composition, blood chemistry, and lower-body strength will be conducted following the week 6 to conclude the study.

NCT ID: NCT05813262 Completed - Anesthesia Clinical Trials

Patient Opinions Regarding General Anesthesia, Before and After Having Undergone a Procedure.

Start date: May 3, 2022
Phase:
Study type: Observational

The goal of this survey will be to assess the opinions and reticence of patients who have undergone surgical procedures that required the usage of general anesthesia both before they underwent the procedure and afterwards.

NCT ID: NCT05812794 Completed - Childhood Stroke Clinical Trials

TOlerability of Transcranial Direct Current Stimulation in Pediatric Stroke Survivors

TOPSS
Start date: June 30, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the tolerability of tDCS in childhood stroke survivors and to assess for improvement in arm function in patients receiving tDCS and occupational therapy

NCT ID: NCT05812781 Completed - Clinical trials for Cryopyrin Associated Periodic Syndrome

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome

Explore
Start date: March 18, 2023
Phase: Phase 2
Study type: Interventional

This is a study to understand if taking VTX2735 is safe and effective in participants diagnosed with Cryopyrin-Associated Period Syndrome (CAPS). Approximately 10 patients will take VTX2735 Dose A or VTX2735 Dose B. The study consists of a screening/washout period of up to 28 weeks, a 2 week treatment period, a treatment withdrawal period of up to 2 weeks, another 2 week treatment period, and a 4 week follow up period. The maximum length of treatment is 4 weeks.

NCT ID: NCT05812599 Completed - Communication Clinical Trials

Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

Start date: September 22, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to identify promising health education strategies and culturally appropriate messages for use by 2-1-1 practitioners to promote coronavirus disease of 2019 (COVID) testing behaviors. Previous study findings and evidence-based health communication and education tactics were integrated to create an interactive learning module that includes four narrative scenarios, illustrations, and accompanying questions and responses that inform the audience about COVID testing guidelines. The study will test the effectiveness of the interactive learning module with 2-1-1 callers (n=300) in Connecticut, North Carolina, and Nebraska. Participants' contact information will be shared with us by 2-1-1 with the participants' given consent. The study team will send the potential participant via text message a link to a survey that includes a screen where they will provide informed consent. Those who provide consent will be randomly assigned to receive one of two surveys. The inclusion of the interactive learning module is what varies across the surveys. An experimental group will receive the learning module with a study team-developed pre- and post-survey, and the control group will receive only the study team-developed pre- and post-survey. The post-survey contains questions regarding information covered in the interactive learning module. It is hypothesized that those who complete the interactive learning module in the experimental group will score better on the post-survey questions when compared to the control group. All participants, regardless of experimental or control condition, will receive an information sheet with the most up-to-date scientific guidelines for COVID testing.

NCT ID: NCT05812352 Completed - Hemorrhage Clinical Trials

Supporting Laypeople Addressing Prehospital Hemorrhage Study

SLAPS
Start date: January 24, 2023
Phase: N/A
Study type: Interventional

It is unknown if bystanders equipped with point-of-care (POC) instruction are as effective as bystanders with in-person training for bleeding control. Therefore, POC instructional interventions were developed during this study in response to the scalability challenges associated with in-person training to measure the comparative effectiveness and skill retention of POC instructions vs in-person training using a randomized clinical trial design.